These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11882080)

  • 1. Porcine factor VIII: current status and future developments.
    Hay CR
    Haemophilia; 2002 Jan; 8 Suppl 1():24-7; discussion 28-32. PubMed ID: 11882080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine factor VIII: past, present and future.
    Hay CR
    Haematologica; 2000 Oct; 85(10 Suppl):21-4; discussion 24-5. PubMed ID: 11187865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of porcine factor VIII in patients with haemophilia A and high-responding inhibitors: stability and clinical experience.
    O'Gorman P; Dimichele DM; Kasper CK; Mannucci PM; Santagostini E; Hay CR
    Haemophilia; 2001 Nov; 7(6):537-43. PubMed ID: 11851750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous infusion of porcine factor VIII: stability, microbiological safety and clinical experience.
    DiMichele DM; Gorman PO; Kasper CK; Mannucci PM; Santagostino E; Hay CR
    Haemophilia; 2002 Jan; 8 Suppl 1():9-12; discussion 28-32. PubMed ID: 11882076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activation and hypercoagulability following treatment with porcine factor VIII (HYATE:C).
    Freedman J; Mody M; Lazarus AH; Dewar L; Song S; Blanchette VS; Garvey MB; Ofosu FA
    Am J Hematol; 2002 Mar; 69(3):192-9. PubMed ID: 11891806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral pharmacovigilance study of haemophiliacs receiving porcine factor VIII.
    Giangrande PL; Kessler CM; Jenkins CE; Weatherill PJ; Webb PD
    Haemophilia; 2002 Nov; 8(6):798-801. PubMed ID: 12410650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion of porcine factor VIII in the management of patients with factor VIII inhibitors.
    Rubinger M; Houston DS; Schwetz N; Woloschuk DM; Israels SJ; Johnston JB
    Am J Hematol; 1997 Oct; 56(2):112-8. PubMed ID: 9326353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence that the residual vWf:Ag in porcine FVIII:C induces human platelet aggregation.
    Saniabadi AR; Marney Y; Belch JJ; Lowe GD; Barbenel JC; Madhok R; Forbes CD
    Haemostasis; 1990; 20(5):289-95. PubMed ID: 2127038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant B-domain-deleted porcine sequence factor VIII (r-pFVIII) for the treatment of bleeding in patients with congenital haemophilia A and inhibitors.
    Mahlangu JN; Andreeva TA; Macfarlane DE; Walsh C; Key NS
    Haemophilia; 2017 Jan; 23(1):33-41. PubMed ID: 27761964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic stroke associated with the use of porcine factor VIII in a patient with acquired haemophilia.
    Ashrani AA; Reding MT; Greeno EW; Shet A; Key NS
    Haemophilia; 2002 Jan; 8(1):56-8. PubMed ID: 11886466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A.
    Kempton CL; Abshire TC; Deveras RA; Hoots WK; Gill JC; Kessler CM; Key NS; Konkle BA; Kuriakose P; Macfarlane DE; Bergman G
    Haemophilia; 2012 Sep; 18(5):798-804. PubMed ID: 22512291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of porcine parvovirus among persons with hemophilia receiving Hyate:C porcine factor VIII concentrate.
    Soucie JM; Erdman DD; Evatt BL; Anderson LJ; Török TJ; El-Jamil M; Barnhart E; Tepper M; Burrill HN; Pickett AM; Mengeling WL
    Transfusion; 2000 Jun; 40(6):708-11. PubMed ID: 10864993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international survey.
    Hay CR; Lozier JN; Lee CA; Laffan M; Tradati F; Santagostino E; Ciavarella N; Schiavoni M; Fukui H; Yoshioka A; Teitel J; Mannucci PM; Kasper CK
    Thromb Haemost; 1996 Jan; 75(1):25-9. PubMed ID: 8713775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant porcine factor VIII for high-risk surgery in paediatric congenital haemophilia A with high-titre inhibitor.
    Croteau SE; Abajas YL; Wolberg AS; Nielsen BI; Marx GR; Baird CW; Neufeld EJ; Monahan PE
    Haemophilia; 2017 Mar; 23(2):e93-e98. PubMed ID: 28124406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine recombinant factor VIII (Obizur; OBI-1; BAX801): product characteristics and preclinical profile.
    Lillicrap D; Schiviz A; Apostol C; Wojciechowski P; Horling F; Lai CK; Piskernik C; Hoellriegl W; Lollar P
    Haemophilia; 2016 Mar; 22(2):308-317. PubMed ID: 26278557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of spontaneous inhibitors in children with porcine factor VIII.
    Kobrinsky NL; Stegman D; Sjolander D
    Haemophilia; 2002 Jan; 8 Suppl 1():1-4; discussion 28-32. PubMed ID: 11882074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of recombinant anti-haemophilic porcine sequence factor VIII in adults with acquired haemophilia A.
    Fosbury E; Drebes A; Riddell A; Chowdary P
    Ther Adv Hematol; 2017 Sep; 8(9):263-272. PubMed ID: 29051804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-delivered factor VIII provides limited resistance to anti-factor VIII inhibitors.
    Gewirtz J; Thornton MA; Rauova L; Poncz M
    J Thromb Haemost; 2008 Jul; 6(7):1160-6. PubMed ID: 18433455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience.
    Brettler DB; Forsberg AD; Levine PH; Aledort LM; Hilgartner MW; Kasper CK; Lusher JM; McMillan C; Roberts H
    Arch Intern Med; 1989 Jun; 149(6):1381-5. PubMed ID: 2499293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor contaminating porcine factor VIII concentrate (Hyate:C) causes platelet aggregation.
    Altieri DC; Capitanio AM; Mannucci PM
    Br J Haematol; 1986 Aug; 63(4):703-11. PubMed ID: 2942172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.